FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “EPIQUANT”, which is offered here for In the statement, column 1, lines 1-3,millipore corporation (massachusetts corporation) 290 concord road billerica, ma 01821 should be deleted, and merck kgaa (germany kommanditgesellschaft auf aktien) frankurter strasse 250 d-64293 darmstadt germany should be inserted.;reagents, protein arrays, microfluidics, assays, and sample preparation kits comprising chemicals, buffer solutions, filters and separation tubes, and protein dna and genetic sequences, all for use in scientific, pharmaceutical, biotechnological and medical research and laboratories, for the identification, measurement, manipulation and analysis of multiple proteins and isoforms of proteins using capture agents against linear peptide sequences within proteins, including detection of post translational modification sites, including phosphorylation, within proteins and protein pathways;.
Its status is currently believed to be active. Its class is unavailable. “EPIQUANT” is believed to be currently owned by “MERCK KGAA”.
| Owner: |
MERCK KGAA
Owner Details |
|---|---|
| Description: |
In the statement, Column 1, lines 1-3,MILLIPORE CORPORATION (MASSACHUSETTS CORPORATION) 290 CONCORD ROAD BILLERICA, MA 01821 should be deleted, and Merck KGaA (Germany kommanditgesellschaft auf aktien) Frankurter Strasse 250 D-64293 Darmstadt Germany should be inserted.;Reagents, protein arrays, microfluidics, assays, and sample preparation kits comprising chemicals, buffer solutions, filters and separation tubes, and protein DNA and genetic sequences, all for use in scientific, pharmaceutical, biotechnological and medical research and laboratories, for the identification, measurement, manipulation and analysis of multiple proteins and isoforms of proteins using capture agents against linear peptide sequences within proteins, including detection of post translational modification sites, including phosphorylation, within proteins and protein pathways;
|
| Categories: | STATEMENT |